Authors explore complexities in scaling gene-therapy production with special attention is to monitoring and enhancing ...

Non-profit life sciences incubator Massachusetts Biomedical Initiatives (MBI) announced that three new companies joined its ...

We speak with a member of BioProcess International's editorial advisory board about the link between friendship and business.

But before we say goodbye to 2025, we leave you with five of our favorite features from this year, delving deeper into a few ...

Cell-line development enhances biopharmaceutical production capacity and quality, but complex biologics like bsAbs and ADCs ...

BPI contributor Justin Byers is cofounder and chief executive officer of Axio BioPharma.

A new clinical trial has shown promising safety and efficacy results for liraglutide in the treatment of Alzheimer’s disease.

Biotechnology company Leucid Bio announced a strategic collaboration with Syenex, an open-source gene therapy platform firm.

The company is struggling to make ends meet as it loses a major undisclosed client.

The PrIMAVeRa project develops a platform to evaluate how mAbs can combat AMR by reducing antibiotic use and providing ...

The 13 partners hope their research into establishing a universal test can help save time and money for therapy developers.

Because of NextCell’s algorithm that allows optimized donor choice for MSC production, its therapy could be completely ...